alustal european dust mite extract european house dust mite 10.0 ir/ml injection suspension vial
stallergenes australia pty ltd - european house dust mite extract, quantity: 10 ir/ml - injection, suspension - excipient ingredients: mannitol; aluminium hydroxide hydrate; sodium chloride; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.
neurolite
lantheus mi australia pty ltd - bicisate dihydrochloride -
cerezyme
pharmacy retailing (nz) ltd t/a healthcare logistics - imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells); - powder for infusion - 40 u/ml - active: imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells) excipient: citric acid monohydrate mannitol nitrogen polysorbate 80 sodium citrate dihydrate - cerezyme is indicated for long - term enzyme replacement therapy for patients with a confirmed diagnosis of non-neuronopathic (type 1) or chronic neuronopathic (type 3) gaucher disease who exhibit clinically significant non-neurological manifestations of the disease. the non-neurological manifestations of gaucher disease include one or more of the following conditions: a) anaemia; b) thrombocytopenia; c) bone disease; d) hepatomegaly or splenomegaly.
skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - pituitary and hypothalamic hormones and analogues - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),
dapsone
link medical products pty ltd t/a link pharmaceuticals - dapsone -
nardil
link medical products pty ltd t/a link pharmaceuticals - phenelzine sulfate -
hydrea
link pharmaceuticals ltd - hydroxycarbamide 500mg; - capsule - 500 mg - active: hydroxycarbamide 500mg excipient: citric acid dibasic sodium phosphate dodecahydrate erythrosine gelatin indigo carmine iron oxide yellow lactose monohydrate magnesium stearate opacode black s-1-277002 titanium dioxide - significant tumour response to hydrea (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent metastatic or inoperable carcinoma of the ovary. hydrea used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip, and carcinoma of the cervix.
tadalafil aristo pharma 5mg film-coated tablets
aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals
tadalafil aristo pharma 10mg film-coated tablets
aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 10 mg - urologicals
tadalafil aristo pharma 20mg film-coated tablets
aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals